Make an appointment with a cancer specialist today.
Call us at 800-KARMANOS (800-527-6266)


Vote for Karmanos' Dr. LoRusso for “Researcher of the Year Award”

Patricia LoRusso, D.O., director of the Eisenberg Center for Translational Therapeutics at the Barbara Ann Karmanos Cancer Institute, is one of only six researchers who have been nominated for the inaugural Researcher of the Year Award through The Gateway for Cancer Research, a nonprofit organization based in Schaumburg, Ill., that funds Phase I and Phase II cancer clinical trials across the world.

You can acknowledge Dr. LoRusso’s ground breaking accomplishments by voting for her by clicking Voting closes April 15.

The winner of the award will receive $30,000 for cancer research projects and a commemorative award. Gateway will announce the winner at its Annual Meeting May 14 in Chicago among peers in the research community; members of Gateway’s Board of Directors and Board of Scientific Counselors; and Gateway supporters.

“With this award, our intent is to lift high the significant contributions and new treatment discoveries made by Gateway-funded researchers,” said Eveline Mumenthaler, director of research and grants at The Gateway for Cancer Research. “What’s more, this award brings to light the important and continued need for innovation in cancer research, while also celebrating the positive impact new discoveries have made to the lives of both cancer patients and their families.”

Nominees for the award include clinical investigators who are currently funded by Gateway or have previously received a Gateway grant, are committed to discovering new treatments, and have made measureable and impactful contributions to the field of cancer research with the goal to improve the lives of today’s cancer patients.

Let’s show our support for Karmanos Cancer Institute’s Dr. LoRusso by voting today!

© 2014 Karmanos Cancer Institute Pencil
The Barbara Ann Karmanos Cancer Center is accredited by The Joint Commission.
If members of the public have any quality-of-care or safety concerns, they may notify The Joint Commission at 630-792-5800.